Merrimack Pharmaceuticals... (MACK)
NASDAQ: MACK
· Real-Time Price · USD
15.14
0.01 (0.07%)
At close: May 17, 2024, 9:59 PM
Merrimack Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -436K | -240K | -279K | -391K | -271K | -492K | -442K | -478K | -132K | -475K | -525K | -759K | -696K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 48K | 48K | 48K | 47K | 17K | 17K | 17K | 17K | 20K | 43K | 53K | 93K | 208K |
Other Working Capital | 101K | 82K | 85K | -246K | 126K | 142K | 161K | -355K | 201K | 198K | n/a | n/a | 187K |
Other Non-Cash Items | -1.23M | -133K | -139K | -26K | -139K | 17K | 17K | 140K | -445K | n/a | -94K | n/a | -50K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 226K | 30K | 167K | -298K | 37K | 290K | 161K | -478K | 203K | 77K | 121K | 1.69M | 101K |
Operating Cash Flow | -1.31M | -295K | -203K | -668K | -356K | -185K | -264K | -939K | -354K | -355K | -445K | 1.02M | -437K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | 225M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -5.93M | -6.84M | -8.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 3M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 225M | 68.00 | 3M | -8.81K | 139K | n/a | n/a | n/a | 445K | n/a | 94K | n/a | 50K |
Investing Cash Flow | 228M | 68K | -3.85M | -8.81M | 139K | n/a | n/a | n/a | 445K | n/a | 94K | n/a | 50K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.49M | 133K | n/a | 209K | 179K | 6.53M | n/a | n/a | n/a | n/a | n/a | n/a | 239K |
Financial Cash Flow | 1.49M | 133K | n/a | 209K | 179K | 6.53M | n/a | n/a | n/a | n/a | n/a | n/a | 239K |
Net Cash Flow | 228.17M | -94K | -4.05M | -9.27M | -38K | 6.35M | -264K | -939K | 91K | -355K | -351K | 1.02M | -148K |
Free Cash Flow | -1.31M | -295K | -203K | -668K | -356K | -185K | -264K | -939K | -354K | -355K | -445K | 1.02M | -437K |